Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. (Record no. 22741942)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02108 a2200601 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516150906.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201309s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-4457 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1473-3099(13)70093-8 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Eron, Joseph J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20130904 |
| 245 00 - TITLE STATEMENT | |
| Title | Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Infectious diseases |
| Date of publication, distribution, etc. | Jul 2013 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 587-96 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-HIV Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | CD4 Lymphocyte Count |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug-Related Side Effects and Adverse Reactions |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV-1 |
| General subdivision | isolation & purification |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Placebos |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrrolidinones |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Raltegravir Potassium |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Salvage Therapy |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Viral Load |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cooper, David A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Steigbigel, Roy T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Clotet, Bonaventura |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gatell, Jose M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kumar, Princy N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rockstroh, Jurgen K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schechter, Mauro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Markowitz, Martin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yeni, Patrick |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Loutfy, Mona R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lazzarin, Adriano |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lennox, Jeffrey L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Strohmaier, Kim M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wan, Hong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barnard, Richard J O |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nguyen, Bach-Yen T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Teppler, Hedy |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Infectious diseases |
| Related parts | vol. 13 |
| -- | no. 7 |
| -- | p. 587-96 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1473-3099(13)70093-8">https://doi.org/10.1016/S1473-3099(13)70093-8</a> |
| Public note | Available from publisher's website |
No items available.